Toggle Nav
Close
  • Menu
  • Setting

Anti-PCSK9 Antibody (Tafolecimab)

Catalog No.
F1459
Anti-PCSK9 Antibody (Tafolecimab)
Grouped product items
SizePriceStock Qty
100ug
$90.00
Ship with 3-5 days
1mg
$270.00
Ship with 3-5 days
5mg
$756.00
Ship with 3-5 days
50mg
$2,533.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Tafolecimab (IBI-306) is a humanized IgG2 monoclonal antibody that specifically bindsPCSK-9 It also reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of low-density lipoprotein receptors, thereby enhancing the clearance of LDL-C, leading to lower LDL-C levels. Tafolecimab can be used in the study of hypercholesterolemia.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.34 kDa

Shipping

Dry ice

Cas No.

2225109-03-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

IBI-306

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q8NBP7

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Isotype

IgG2SA

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

PCSK9

Note

Please avoid freeze-thaw cycles.